Mirum Pharmaceuticals, Inc. · 13 hours ago
Senior Manager, SEC Reporting & Technical Accounting
Mirum Pharmaceuticals is a biopharmaceutical company dedicated to transforming the treatment of rare diseases. As Senior Manager, SEC Financial Reporting and Technical Accounting, you will prepare financial statements in compliance with US GAAP and SEC guidelines and serve as a technical accounting expert while managing the SOX program for the organization.
BiotechnologyHealth CarePharmaceuticalTherapeutics
Responsibilities
Assist in the preparation of the quarterly and annual SEC filing on Forms 10-K and 10Q
Compile financial statements and footnote disclosures, as well as assist in analysis for management disclosures and other SEC disclosures
Ensure financial statements are prepared in accordance with US GAAP and SEC regulations, including newly issued accounting pronouncements
Perform technical accounting research as needed on significant or unusual transactions
Assist with ASC 606 revenue recognition matters for the company
Recommend, implement, maintain and communicate accounting policies and procedures to ensure integrity and consistency of application throughout the organization
Responsible for stock-based compensation accounting
Assist with the Company’s 404 SOX compliance program including evaluating the adequacy of controls at existing and proposed new service organizations based on reporting provided by the service organizations
Work with Company’s external SOX partners to ensure timely completion of management testing of controls
Assist with preparation of the annual proxy statement and other ad hoc filings
Prepare supporting schedules for audit committee presentations
Other ad hoc projects as needed
Qualification
Required
Strong US GAAP and compliance experience
Minimum 5 years of progressive accounting experience including 2-3 years in a public company, at a minimum
CPA required
Bachelor or master's degree in accounting
Candidate performs with strong sense of urgency and works effectively under deadlines
Attention to detail and ability to multi-task
Strong written and verbal communication skills
Strong work ethic
Strong analytical skill
Self-starter with ability to prioritize workload
Preferred
CPA and Big Four experience auditing biotech companies is strongly preferred
Workiva experience preferred
SEC reporting, technical accounting experience, plus operations in a SOX 404(b) environment preferred
Company
Mirum Pharmaceuticals, Inc.
Mirum Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to transforming the treatment of rare diseases affecting children and adults.
Funding
Current Stage
Public CompanyTotal Funding
$765.5MKey Investors
TCG CrossoverOberland CapitalNew Enterprise Associates
2025-12-19Post Ipo Equity· $68.5M
2025-12-08Post Ipo Equity· $200M
2023-04-12Post Ipo Equity· $275M
Recent News
2025-12-30
2025-12-19
2025-12-15
Company data provided by crunchbase